In VivoPharmacokinetics of Phosphorothioate Oligonucleotides Containing Contiguous Guanosines

This publication has 14 references indexed in Scilit:

• In VivoMetabolic Profile of a Phosphorothioate Oligodeoxyribonucleotide
  Antisense and Nucleic Acid Drug Development, 1997
• Mixed-backbone oligonucleotides as second generation antisense oligonucleotides: In vitro and in vivo studies
  Proceedings of the National Academy of Sciences, 1997
• In vivo studies with antisense oligonucleotides
  Trends in Pharmacological Sciences, 1997
• Antisense oligonucleotides: towards clinical trials
  Trends in Biotechnology, 1996
• Effect of G-rich sequences on the synthesis, purification, hybridization, cell uptake, and hemolytic activity of oligonucleotides
  Bioorganic & Medicinal Chemistry Letters, 1996
• Absorption, tissue distribution and in vivo stability in rats of a hybrid antisense oligonucleotide following oral administration
  Biochemical Pharmacology, 1995
• Pharmacokinetics and tissue distribution in rats of an oligodeoxynucleotide phosphorothioate (GEM 91) developed as a therapeutic agent for human immunodeficiency virus type-1
  Biochemical Pharmacology, 1995
• Pharmacokinetics of Antisense Oligonucleotides
  Clinical Pharmacokinetics, 1995
• Self-stabilized antisense oligodeoxynucleotide phosphorothioates: properties and anti-HIV activity
  Nucleic Acids Research, 1993
• Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice.
  Proceedings of the National Academy of Sciences, 1991